Log in to save to my catalogue

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of c...

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3991223

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

About this item

Full title

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2013-11, Vol.1 (Suppl 1), p.P212-P212

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Client-owned pet dogs represent exceptional translational models for advancement of Cancer Research, as they reflects the complex heterogeneity observed in human cancer. We have recently shown that a genetic vaccine targeting dog telomerase (dTERT) and based on Ad/DNA-EGT technology can induce strong cell-mediated immune responses against this tumo...

Alternative Titles

Full title

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3991223

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3991223

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/2051-1426-1-S1-P212

How to access this item